MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale and
issuance of securities,...
$10,859K
Net cash provided by
financing activities
$10,048K
Canceled cashflow
$811K
Net change in cash,
cash equivalents and...
$3,430K
Canceled cashflow
$6,618K
Repayment of convertible
notes payable
$811K
Stock-based compensation
$27K
Depreciation expense
$8K
Net cash used in
operating activities
-$6,613K
Effect of currency
exchange rate changes on...
-$5K
Canceled cashflow
$35K
Gain on changes in
fair value of...
-$3,663K
Net loss
-$1,156K
Accounts payable and
accrued liabilities
-$939K
Prepaid expenses and
other current assets
$359K
Accounts and other
receivables
$328K
Inventory
$92K
Bad debt recovery
-$67K
Gain on
extinguishment of debt
$24K
Other noncash items
$14K
Deferred income tax
-$6K
Back
Back
Cash Flow
source: myfinsight.com
ReShape Lifesciences Inc. (RSLS)
ReShape Lifesciences Inc. (RSLS)